{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:14:56Z","timestamp":1785842096892,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ygyno.2009.04.035","type":"journal-article","created":{"date-parts":[[2009,5,23]],"date-time":"2009-05-23T08:29:29Z","timestamp":1243067369000},"page":"365-369","source":"Crossref","is-referenced-by-count":33,"title":["Age-appropriate use of human papillomavirus vaccines in the U.S."],"prefix":"10.1016","volume":"114","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fetterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israh","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujtaba","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2009.04.035_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2009.04.035_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"pidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2009.04.035_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","article-title":"Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia","volume":"85","author":"Schiffman","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"issue":"9590","key":"10.1016\/j.ygyno.2009.04.035_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2009.04.035_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2009.04.035_bib6","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.ygyno.2009.04.035_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl. J. Med."},{"issue":"9580","key":"10.1016\/j.ygyno.2009.04.035_bib8","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"9580","key":"10.1016\/j.ygyno.2009.04.035_bib9","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(07)60947-7","article-title":"Papillomavirus vaccines in perspective","volume":"369","author":"Kahn","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ygyno.2009.04.035_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2009.04.035_bib11","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.1016\/j.vaccine.2007.11.068","article-title":"Is viral status needed before vaccination?","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"},{"issue":"10 Suppl","key":"10.1016\/j.ygyno.2009.04.035_bib12","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/cncr.23762","article-title":"Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States","volume":"113","author":"Castle","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2009.04.035_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.ygyno.2009.04.035_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report","volume":"127","author":"Castle","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2009.04.035_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2009.04.035_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2009.04.035_bib17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2009.04.035_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","article-title":"Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination","volume":"100","author":"Goldhaber-Fiebert","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2009.04.035_bib19","series-title":"Excess cervical cancer mortality: a marker for low access to health care in poor communities. National Institutes of Health","author":"Freeman","year":"2007"},{"issue":"RR-2","key":"10.1016\/j.ygyno.2009.04.035_bib20","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2009.04.035_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.ygyno.2009.04.035_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"362","key":"10.1016\/j.ygyno.2009.04.035_bib23","first-page":"1","article-title":"Sexual behavior and selected health measures: men and women 15\u201344 years of age, United States, 2002","author":"Mosher","year":"2005","journal-title":"Adv. Data"},{"issue":"11","key":"10.1016\/j.ygyno.2009.04.035_bib24","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/428779","article-title":"A prospective study of age trends in cervical human papillomavirus acquisition and persistence in guanacaste, costa rica","volume":"191","author":"Castle","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ygyno.2009.04.035_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.ygyno.2009.04.035_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.bjc.6604972","article-title":"Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women","volume":"100","author":"Munoz","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2009.04.035_bib27","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ygyno.2009.04.035_bib28","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/587698","article-title":"Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination","volume":"197","author":"Trottier","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ygyno.2009.04.035_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2009.04.035_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2009.04.035_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2009.04.035_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low Genit. Tract. Dis."},{"issue":"9","key":"10.1016\/j.ygyno.2009.04.035_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5694\/j.1326-5377.2008.tb01760.x","article-title":"\"I want the one for older women\" \u2014 extending the human papillomavirus vaccine population base","volume":"188","author":"Wain","year":"2008","journal-title":"Med. J. Aust."},{"issue":"7","key":"10.1016\/j.ygyno.2009.04.035_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326\u00a0years","volume":"199","author":"Brown","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ygyno.2009.04.035_bib35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16\u201326\u00a0years","volume":"199","author":"Wheeler","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ygyno.2009.04.035_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ygyno.2009.04.035_bib37","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1001\/jama.271.23.1866","article-title":"Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop","volume":"271","author":"Kurman","year":"1994","journal-title":"JAMA"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809002844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809002844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T17:27:16Z","timestamp":1589822836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809002844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0090825809002844"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.04.035","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}